Search research articles
Contact Us
Filters
Showing results (491-500 of 507) with videos related to
Page
of 51
Sort By:
Signal Transduction and Targeted Therapy
|
September 12, 2022
Elaiophylin triggers paraptosis and preferentially kills ovarian cancer drug-resistant cells by inducing MAPK hyperactivation
Guan-Nan Li, Xue-Jiao Zhao, Zhen Wang, et al.
Clinical Epigenetics
|
December 15, 2021
Epigenetic imprinting alterations as effective diagnostic biomarkers for early-stage lung cancer and small pulmonary nodules
Jian Zhou, Tong Cheng, Xing Li, et al.
Vaccine
|
February 14, 2022
Safety and immunogenicity of a plant-derived recombinant protective antigen (rPA)-based vaccine against Bacillus anthracis: A Phase 1 dose-escalation study in healthy adults
Kristopher M Paolino, Jason A Regules, James E Moon, et al.
Nature Cell Biology
|
March 5, 2021
AIDA directly connects sympathetic innervation to adaptive thermogenesis by UCP1
Meng Shi, Xiao-Yu Huang, Xin-Yi Ren, et al.
Biological Psychiatry
|
January 21, 2020
Cyclin-Dependent Kinase 5-Dependent BAG3 Degradation Modulates Synaptic Protein Turnover
Jiechao Zhou, Hei-Man Chow, Yan Liu, et al.
Journal of the Pediatric Infectious Diseases Society
|
May 4, 2023
Evaluation of Clinical Case Definitions for Respiratory Syncytial Virus Lower Respiratory Tract Infection in Young Children
Janet A Englund, Rachel A Cohen, Veronique Bianco, et al.
Malaria Journal
|
January 25, 2013
Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP1(42)) administered intramuscularly with adjuvant system AS01
Nekoye Otsyula, Evelina Angov, Elke Bergmann-Leitner, et al.
Human Vaccines & Immunotherapeutics
|
August 1, 2013
Human adenovirus 5-vectored Plasmodium falciparum NMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection
Cindy Tamminga, Martha Sedegah, Santina Maiolatesi, et al.
BMJ Open
|
January 27, 2025
Chinese herbal formula Tongxie Yaofang granules for diarrhoea-predominant irritable bowel syndrome: a randomised, double-blind, placebo-controlled, phase II trial
Shi-Bing Liang, Hong-Jie Cheng, Qiao-Yan Zhang, et al.
Plos One
|
October 18, 2011
Adenovirus 5-vectored P. falciparum vaccine expressing CSP and AMA1. Part A: safety and immunogenicity in seronegative adults
Martha Sedegah, Cindy Tamminga, Shannon McGrath, et al.
Page
of 51
Search research articles
Search
Showing results (491-500 of 507) with videos related to
Sort By:
Page
of 51
Signal Transduction and Targeted Therapy
|
September 12, 2022
Elaiophylin triggers paraptosis and preferentially kills ovarian cancer drug-resistant cells by inducing MAPK hyperactivation
Guan-Nan Li, Xue-Jiao Zhao, Zhen Wang, et al.
Clinical Epigenetics
|
December 15, 2021
Epigenetic imprinting alterations as effective diagnostic biomarkers for early-stage lung cancer and small pulmonary nodules
Jian Zhou, Tong Cheng, Xing Li, et al.
Vaccine
|
February 14, 2022
Safety and immunogenicity of a plant-derived recombinant protective antigen (rPA)-based vaccine against Bacillus anthracis: A Phase 1 dose-escalation study in healthy adults
Kristopher M Paolino, Jason A Regules, James E Moon, et al.
Nature Cell Biology
|
March 5, 2021
AIDA directly connects sympathetic innervation to adaptive thermogenesis by UCP1
Meng Shi, Xiao-Yu Huang, Xin-Yi Ren, et al.
Biological Psychiatry
|
January 21, 2020
Cyclin-Dependent Kinase 5-Dependent BAG3 Degradation Modulates Synaptic Protein Turnover
Jiechao Zhou, Hei-Man Chow, Yan Liu, et al.
Journal of the Pediatric Infectious Diseases Society
|
May 4, 2023
Evaluation of Clinical Case Definitions for Respiratory Syncytial Virus Lower Respiratory Tract Infection in Young Children
Janet A Englund, Rachel A Cohen, Veronique Bianco, et al.
Malaria Journal
|
January 25, 2013
Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP1(42)) administered intramuscularly with adjuvant system AS01
Nekoye Otsyula, Evelina Angov, Elke Bergmann-Leitner, et al.
Human Vaccines & Immunotherapeutics
|
August 1, 2013
Human adenovirus 5-vectored Plasmodium falciparum NMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection
Cindy Tamminga, Martha Sedegah, Santina Maiolatesi, et al.
BMJ Open
|
January 27, 2025
Chinese herbal formula Tongxie Yaofang granules for diarrhoea-predominant irritable bowel syndrome: a randomised, double-blind, placebo-controlled, phase II trial
Shi-Bing Liang, Hong-Jie Cheng, Qiao-Yan Zhang, et al.
Plos One
|
October 18, 2011
Adenovirus 5-vectored P. falciparum vaccine expressing CSP and AMA1. Part A: safety and immunogenicity in seronegative adults
Martha Sedegah, Cindy Tamminga, Shannon McGrath, et al.
Page
of 51